VZV gB Antibodies

Santa Cruz Biotechnology offers a broad range of VZV gB monoclonal antibodies for research focused on understanding varicella-zoster virus (VZV) glycoprotein B. VZV gB monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VZV glycoprotein B plays a crucial role in the viral entry process and is essential for the fusion of the viral envelope with host cell membranes. Understanding the function of VZV gB is vital for developing therapeutic strategies against VZV-related diseases, including chickenpox and shingles. The study of VZV gB can provide insights into the mechanisms of viral pathogenesis and immune evasion. Researchers investigating VZV gB can explore viral entry mechanisms, membrane fusion events, and host-pathogen interactions. Current research focuses on understanding how VZV gB contributes to viral spread and infection progression. Ongoing studies aim to uncover potential therapeutic targets for treating VZV infections. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of VZV and its impact on human health.